We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App


Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

A new category of blood-based biomarkers has the potential to be developed into improved or new orthogonal tests for predicting tumor responses to immune checkpoint inhibitor (ICIs) therapies. More...
30 May 2023
Image: The first ever diagnostic test accurately predicts patient response to immunotherapy (Photo courtesy of Cofactor)

Predictive Test Improves Immunotherapy Results for Cancer Patients

A new test, that utilizes an advanced multidimensional immune biomarker can predict which cancer patients are likely to respond to monotherapy of immune checkpoint inhibitors like Keytruda. More...
26 May 2023
Image: The Immune Reveal point-of-care system goes beyond routine lab tests (Photo courtesy of Immune IQ)

First-Ever POC Analyzer Reads Patient's Immune System to Detect Diseases Before Symptoms Present

A breakthrough point-of-care diagnostic platform that leverages the power of the human immune system is poised to address the two main challenges associated with sepsis: broad screening and rapid identification. More...
19 May 2023
Image: The single automated device can run hematology, clinical chemistry, and immunoassays subsystems in parallel (Photo courtesy of Freepik)

Single Automated Analyzer to Bring Full Suite of Diagnostics to Wherever Patients Are

A novel platform that delivers swift results using minimal blood volumes incorporates technology that facilitates automation and adaptable form factors outside centralized labs, bridging the gap between diagnostics and treatment. More...
09 May 2023
A study has found that ChemoID platform-predicted treatments led to longer survival (Photo courtesy of Freepik)

Cancer Stem Cell Test Improves Survival of Patients with Deadly Brain Tumor

A new study has found that a cancer stem cell test can accurately determine more effective treatments, resulting in increased survival rates for patients with glioblastoma, a lethal brain tumor. More...
09 May 2023
Image: The new discovery could improve survival of bladder cancer patients (Photo courtesy of Freepik)

Biomarker Signature Test Predicts Which Tumors Will Respond to Immunotherapy

In a breakthrough that could enhance bladder cancer patients' survival, researchers have now developed a biomarker signature test to predict which tumors will be responsive to immunotherapy. More...
28 Apr 2023
Image: Blood-based biomarkers can accurately predict neuroendocrine tumor response to radiopharmaceutical therapy (Photo courtesy of Freepik)

Simple Blood Test Predicts Neuroendocrine Tumor Response to Radiopharmaceutical Therapy

A new study has revealed that a simple blood test can supply doctors with crucial information to ascertain if peptide receptor radionuclide therapy (PRRT) is likely to be effective in patients with neuroendocrine cancer. More...
11 Apr 2023
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.
Copyright © 2000-2024 Globetech Media. All rights reserved.